Cancer Drug Conatumumab Shows Promise for Peripheral Artery Disease Treatment
Pre-clinical Study Suggests Conatumumab Can Promote Blood Flow Restoration in PAD Patients
Topline:
A recent pre-clinical study suggests that the cancer drug Conatumumab may offer a new treatment option for patients suffering from Peripheral Artery Disease (PAD) by promoting the growth of new blood vessels and restoring blood flow.
Peripheral Artery Disease (PAD), a condition characterized by the narrowing of arteries in the lower limbs, often…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.